Navigation Links
Postcards from the photosynthetic edge
Date:7/9/2014

A crucial piece of the puzzle behind nature's ability to split the water molecule during photosynthesis that could help advance the development of artificial photosynthesis for clean, green and renewable energy has been provided by an international collaboration of scientists led by researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab) and the SLAC National Accelerator Laboratory.

Working at SLAC's Linac Coherent Light Source (LCLS), the world's most powerful x-ray laser, the researchers were able to take detailed "snapshots" of the four photon-step cycle for water oxidation in photosystem II, a large protein complex in green plants. Photosystem II is the only known biological system able to harness sunlight for the oxidation of water into molecular oxygen.

"An effective method of solar-based water-splitting is essential for artificial photosynthesis to succeed but developing such a method has proven elusive," says Vittal Yachandra, a chemist with Berkeley Lab's Physical Biosciences Division and one of the leaders of this study. "Using femtosecond x-ray pulses for the simultaneous collection of both x-ray diffraction (XRD) and x-ray emission spectroscopy (XES) data at room temperature, we have gone around the four-step catalytic cycle of photosynthetic water oxidation in photosystem II. This represents a major advance towards the real time characterization of the formation of the oxygen molecule in photosystem II, and has yielded information that should prove useful for designing artificial solar-energy based devices to split water."

Photo-oxidation of water by photosystem II is responsible for most of the oxygen in Earth's atmosphere. At the core of photosystem II is a manganese-calcium (Mn4Ca) metalloenzyme complex that when energized by solar photons catalyzes a four photon-step cycle of oxidation states (S0-to-S3) that ultimately yields molecular oxygen. Scientists need to observe intact x-ray crystallography of the Mn4Ca ion in action but the molecule is highly sensitive to radiation. The LCLS is the world's only source of x-rays capable of providing femtosecond pulses at the high intensities that allow intact photosystem II crystals to be imaged before they are destroyed by exposure to the x-ray beams.

"In an earlier study at the LCLS, we reported combined XRD and XES data from photosystem II samples in the dark S1 state and the one visible-flash illuminated S2 (1-flash) state," says Junko Yano, a chemist also with Berkeley Lab's Physical Biosciences Division and also a leader of this research. "In this new study we report data from the S3 (2-flash) and S0 (3-flash) states, which are the intermediate states directly before and after the evolution of the oxygen molecule. In addition, we report data for the first time from a light-induced transient state between the S3 and S0 states, which opens the window for elucidating the mechanism of oxygen-oxygen bond formation that occurs between these two states."

XRD data of all the flash states studied revealed an anomalous diffraction signal from Mn that is not complicated by signals from the overall protein matrix of carbon, nitrogen, oxygen and other metals, or even by the Ca atom, which is a part of the five atom Mn4Ca metalloenzyme complex.

"The detection of this anomalous Mn scattering signal not only validates the quality of our data, but also the procedures used for analyzing the data," says computational scientist Nicholas Sauter. Sauter and Paul Adams, both with Berkeley Lab's Physical Biosciences Division and both contributors to this study, are leading an effort to develop methods for analyzing data from the LCLS.

Yachandra and Yano believe that the detection of an anomalous Mn scattering signal opens up the possibility for detecting changes pertaining only to the Mn cluster as it advances through the S-state cycles and the oxygen-oxygen bond formation, which is where the catalytic action is taking place.

"Knowing how this happens is important for understanding the design principles used in natural photosynthesis," Yachandra says.


'/>"/>

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory
Source:Eurekalert  

Related biology news :

1. Scientists stitch up photosynthetic megacomplex
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Postcards from the photosynthetic edge
(Date:2/13/2017)... Feb. 13, 2017 Former 9/11 Commission border ... Committee, Janice Kephart of Identity Strategy Partners, ... Donald Trump,s "Executive Order: Protecting the Nation From ... 2017):  "As President Trump,s ,Travel Ban, Executive ... now essentially banned the travel ban, it is important ...
(Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
(Date:2/8/2017)... (NASDAQ: AWRE ), a leading supplier of biometrics ... and year ended December 31, 2016. Revenue ... to $6.9 million in the same quarter last year. Operating ... compared to $2.6 million in the fourth quarter of 2015. ... million, or $0.02 per diluted share, which compares to $1.8 ...
Breaking Biology News(10 mins):
(Date:2/28/2017)... Norwood, MA (PRWEB) , ... February 28, 2017 ... ... successful clinical trials, yet requires extensive coordination and expertise. Colpitts Clinical Trial ... is celebrating 15 years of meeting this unique need within the biotechnology and ...
(Date:2/28/2017)... ... February 28, 2017 , ... GigaGen Inc ., a ... repertoires, today announced a strategic partnership with Trianni, Inc. , a biotechnology ... antibodies. The partnership will use GigaGen technology to discover immuno-oncology antibody therapeutics through ...
(Date:2/28/2017)... 28, 2017 Sangamo Therapeutics, Inc. (NASDAQ: ... reported its fourth quarter and full year 2016 ... this year we rebranded our company as Sangamo ... genomic therapies using our industry leading platform technologies ... cell therapy," said Sandy Macrae , CEO ...
(Date:2/27/2017)... VANCOUVER , Feb. 27, 2017 /PRNewswire/ - InMed Pharmaceuticals, ... to their expiry on Friday, February 24, 2017 a total ... a price of $0.13 per common share. Proceeds from the ... were issued from InMed,s Treasury.   ... "We are grateful for this expression ...
Breaking Biology Technology: